The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chun, S.
Right arrow Articles by Rouse, B. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chun, S.
Right arrow Articles by Rouse, B. T.
The Journal of Immunology, 1999, 163: 2393-2402.
Copyright © 1999 by The American Association of Immunologists

Distribution Fate and Mechanism of Immune Modulation Following Mucosal Delivery of Plasmid DNA Encoding IL-101

Sangjun Chun, Massoud Daheshia, Sujin Lee, Seong Kug Eo and Barry T. Rouse2

Department of Microbiology, University of Tennessee, Knoxville, TN 37996

DNA vaccination has been widely studied in several models of vaccination and in the treatment of inflammatory diseases, even though the mechanism involved is still unclear. This report demonstrates that mucosal administration of plasmid DNA leads to rapid and widespread distribution around the body. Dissemination likely occurred via the bloodstream because plasmid DNA was present in blood plasma. The plasmid DNA was also detectable in several tissues including draining lymph nodes, spleen, liver, bone marrow, and even the dermis of ear pinnae. Except for the site of administration, plasmid DNA was no longer detectable in tissues after 3 wk postadministration. RNA and protein expression was also found in the tissues and bloodstream. Animals previously primed by HSV infection and subsequently given IL-10 DNA via the nasal mucosa, showed diminished Ag-induced delayed type hypersensitivity reactions for up to 5 wk posttreatment. The mechanism of modulation involved diminished the Ag-specific proliferation and production of Th1 cytokines. The Ag-specific silencing effects persisted beyond the duration of detectable plasmid encoded protein and was maintained upon adoptive transfer of T cells into a plasmid-free environment. The silenced T cells were not a source of IL-10, and their anergic state was reversible by exposure to Ag in the presence of exogenous IL-2.




This article has been cited by other articles:


Home page
J. Virol.Home page
J. Zhang, N. Silvestri, J. L. Whitton, and D. E. Hassett
Neonates Mount Robust and Protective Adult-Like CD8+-T-Cell Responses to DNA Vaccines
J. Virol., October 25, 2002; 76(23): 11911 - 11919.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
V. del Pozo, M. Rojo, M. L. Rubio, I. Cortegano, B. Cardaba, S. Gallardo, M. Ortega, E. Civantos, E. Lopez, C. Martin-Mosquero, et al.
Gene Therapy with Galectin-3 Inhibits Bronchial Obstruction and Inflammation in Antigen-challenged Rats through Interleukin-5 Gene Downregulation
Am. J. Respir. Crit. Care Med., September 1, 2002; 166(5): 732 - 737.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
D. S. Southam, M. Dolovich, P. M. O'Byrne, and M. D. Inman
Distribution of intranasal instillations in mice: effects of volume, time, body position, and anesthesia
Am J Physiol Lung Cell Mol Physiol, April 1, 2002; 282(4): L833 - L839.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. K. Eo, U. Kumaraguru, and B. T. Rouse
Plasmid DNA Encoding CCR7 Ligands Compensate for Dysfunctional CD8+ T Cell Responses by Effects on Dendritic Cells
J. Immunol., October 1, 2001; 167(7): 3592 - 3599.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
N. H. Gruener, F. Lechner, M.-C. Jung, H. Diepolder, T. Gerlach, G. Lauer, B. Walker, J. Sullivan, R. Phillips, G. R. Pape, et al.
Sustained Dysfunction of Antiviral CD8+ T Lymphocytes after Infection with Hepatitis C Virus
J. Virol., June 15, 2001; 75(12): 5550 - 5558.
[Abstract] [Full Text]


Home page
Exp. Biol. Med.Home page
D. J.J. Carr, P. Härle, and B. M. Gebhardt
The Immune Response to Ocular Herpes Simplex Virus Type 1 Infection
Experimental Biology and Medicine, May 1, 2001; 226(5): 353 - 366.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
S. K. Eo, M. Gierynska, A. A. Kamar, and B. T. Rouse
Prime-Boost Immunization with DNA Vaccine: Mucosal Route of Administration Changes the Rules
J. Immunol., May 1, 2001; 166(9): 5473 - 5479.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Harle, S. Noisakran, and D. J. J. Carr
The Application of a Plasmid DNA Encoding IFN-{{alpha}}1 Postinfection Enhances Cumulative Survival of Herpes Simplex Virus Type 2 Vaginally Infected Mice
J. Immunol., February 1, 2001; 166(3): 1803 - 1812.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. K. Eo, S. Lee, S. Chun, and B. T. Rouse
Modulation of Immunity against Herpes Simplex Virus Infection via Mucosal Genetic Transfer of Plasmid DNA Encoding Chemokines
J. Virol., January 15, 2001; 75(2): 569 - 578.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
U. Kumaraguru, R. J. D. Rouse, S. K. Nair, B. D. Bruce, and B. T. Rouse
Involvement of an ATP-Dependent Peptide Chaperone in Cross-Presentation After DNA Immunization
J. Immunol., July 15, 2000; 165(2): 750 - 759.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
A. Kitani, I. J. Fuss, K. Nakamura, O. M. Schwartz, T. Usui, and W. Strober
Treatment of Experimental (Trinitrobenzene Sulfonic Acid) Colitis by Intranasal Administration of Transforming Growth Factor (TGF)-{beta}1 Plasmid: TGF-{beta}1-mediated Suppression of T Helper Cell Type 1 Response Occurs by Interleukin (IL)-10 Induction and IL-12 Receptor {beta}2 Chain Downregulation
J. Exp. Med., June 26, 2000; 192(1): 41 - 52.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Noisakran and D. J. J. Carr
Plasmid DNA Encoding IFN-{alpha}1 Antagonizes Herpes Simplex Virus Type 1 Ocular Infection Through CD4+ and CD8+ T Lymphocytes
J. Immunol., June 15, 2000; 164(12): 6435 - 6443.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.